Clinical trials
Completed Phase 4 Hyperphosphatemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ardelyx | 2 |
| Ain Shams University | 1 |
| Chugai Pharma Taiwan | 1 |
| Fresenius Medical Care North America | 1 |
| Kaiser Permanente | 1 |
| Nabi Biopharmaceuticals | 1 |
| Panion & BF Biotech Inc. | 1 |
| Papageorgiou General Hospital | 1 |
| USRC Kidney Research | 1 |
| University of Colorado, Denver | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperphosphatemia | 12 |
| Kidney Failure, Chronic | 3 |
| Renal Insufficiency | 3 |
| Renal Insufficiency, Chronic | 3 |
| Hyperparathyroidism, Secondary | 2 |
| Anemia, Iron-Deficiency | 1 |
| Arteriosclerosis | 1 |
| Calcinosis | 1 |
| Cardiovascular Diseases | 1 |
| Hypercalcemia | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.